1. Expression and purification of an antimicrobial peptide by fusion with elastin-like polypeptides in Escherichia coli.
- Author
-
Hu F, Ke T, Li X, Mao PH, Jin X, Hui FL, Ma XD, and Ma LX
- Subjects
- Amino Acid Sequence, Antimicrobial Cationic Peptides genetics, Antimicrobial Cationic Peptides pharmacology, Bacteria drug effects, Elastin genetics, Elastin pharmacology, Escherichia coli genetics, Escherichia coli metabolism, Microbial Sensitivity Tests, Molecular Sequence Data, Recombinant Fusion Proteins genetics, Recombinant Fusion Proteins pharmacology, Antimicrobial Cationic Peptides isolation & purification, Antimicrobial Cationic Peptides metabolism, Elastin isolation & purification, Elastin metabolism, Recombinant Fusion Proteins isolation & purification, Recombinant Fusion Proteins metabolism
- Abstract
Different carrier molecules have been fused to antimicrobial polypeptides (AMPs) to facilitate recombinant protein expression and purification. Some of them have improved the stability of AMPs and reduced the toxicity to host cells, but most current strategies still have some problems to be solved such as poor yield, low purity, high expense, time-consumption, and difficulty in scaling-up. Here, we introduced the elastin-like polypeptides (ELPs) as a fusion partner to express an antimicrobial polypeptide halocidin18 (Hal18). By the reversible soluble-insoluble phase transition, 69 mg of the fusion protein were purified from 1 l of culture medium with the purity of nearly 95%. After cleavage with hydroxylamine, the ELP's tag was easily separated from Hal18 in the next round of inverse transition cycle and Hal18 (1.7 mg, approximately 1.9 kDa) was mainly found in the supernatant with a recovery of about 47% and purity of 60%. Antimicrobial activity showed that Hal18 had strong antimicrobial activity against Escherichia coli and Micrococcus luteus but weak activity against Pichia pastoris.
- Published
- 2010
- Full Text
- View/download PDF